Meloxicam Price decrease and the impact on medicare set asides (MSAs)
As you may have heard, meloxicam had a major price decrease within the last month. Meloxicam (generic formulation of Mobic) is a non-steroidal anti-inflammatory (NSAID), which is commonly prescribed for workers’ compensation injuries.
| Drug Name, dose and formulation |
National Drug Code (NDC) |
Drug class | Prior AWP* | New AWP** |
|---|---|---|---|---|
| Meloxicam 15 mg tablet | 76282-0153-10 | NSAID | $4.25/tablet | $0.05/tablet |
| Meloxicam 7.5 mg tablet | 76282-0152-10 | NSAID | $2.78/tablet | $0.05/tablet |
*Current WCMSA portal price
**Expected 4/2020 WCMSAP price
This price change could have a major impact to your Workers’ Compensation Medicare Set-Asides (WCMSAs). For example, if a MSA includes meloxicam 15 mg #30 per month, over a 20 year life expectancy, adjusting the MSA to reflect the new price will decrease the overall cost by $30,240.
Optum is here to help
If you are unsure if any of your open MSAs have meloxicam included in the projection, reach out to us and we will review the file. If you know of claims where the injured worker is taking meloxicam, we can review the file to see if the price change has impacted the potential for settlement. Either way, Optum is your partner.
Stay informed by receiving the latest blogs, articles and more.
